What: Pistoia Alliance’s Collaborate to Innovate Conference
Where: Hilton Boston Back Bay
When: November 1-2, 2022
Register today
Event Summary
Registration is open for the Pistoia Alliance Annual Fall Conference. Collaborate to Innovate is the driving theme of this in-person member event. Join us for a series of plenary presentations, panel discussions, breakout groups, poster presentations, and networking activities as we examine the challenges and opportunities for pre-competitive collaboration across the biopharma value chain. The main conference will be preceded by a day dedicated to reviewing the status of current and proposed Pistoia Alliance projects that aim to lower barriers to innovation in life science R&D.
Project Day, 9am – 6pm, November 1, 2022
The main conference will be preceded by a day dedicated to showcasing and reviewing current and proposed Pistoia Alliance projects that aim to lower barriers to innovation in life science R&D.
Conference Day, 9am – 7:30pm, November 2, 2022
Join us for a series of plenary presentations, panel discussions, breakout groups, poster presentations, and networking activities as we examine the challenges and opportunities for pre-competitive collaboration across the biopharma value chain.
3 Reasons to Attend
- Gain new insights on topical issues from top pharma senior R&D leaders
- Engage in our collaborative projects and help solve shared industry challenges
- Build your industry network at our dedicated evening networking reception
Register today
Hotel Information
A special room rate of $249 + tax has been negotiated for Pistoia Alliance conference delegates staying at the Hilton Boston Back Bay Hotel. To book a room at this rate use this link.
Agenda – Project Day – 1 November 2022
All timings are EST
| EST | Maverick Room |
| 08:30 | Introduction & Announcements |
| 08:45 | DataFAIRy – Biological Assay Metadata FAIR Annotation
Vladimir Makarov, Pistoia Alliance Additional DataFAIRy Team Member |
| 09:15 | GMLP – Emergent Good Machine Learning Practices Community
Vladimir Makarov, Pistoia Alliance |
| 09:30 | The IDMP Ontology Project
Gerhard Noelken, Pistoia Alliance Heiner Oberkampf, CEO and Co-Founder of ACCURIDS |
| 10:15 | Morning Coffee |
| 10:45 | Controlled Substance Compliance & Shipping Expert Community
Jack De Cicco, GSK, Jessie bin Song, Merck Birthe Nielsen, Pistoia Alliance |
| 11:30 | The IDMP Ontology Workshop
Gerhard Noelken, Pistoia Alliance Heiner Oberkampf, ACCURIDS |
| 12.15 | Lunch |
| 13:15 | In Vitro Pharmacology Project
Rebecca Racz, Pharmacologist, FDA Larry Callahan, Chemist, FDA Veronique Francois-Newton, Pistoia Alliance |
| 14:00 | FAIR Implementation
|
| 14.45 | Afternoon Coffee |
| 15:15 | Summary of Lab of the Future sessions and Pistoia Alliance D&I Program
1. Webinar series overview presentation – Improving the Efficiency and Effectiveness of R&D As part of our overall theme of Improving the Efficiency and Effectiveness of R&D, each webinar explores the power of collaboration to solve shared challenges, drive transformation and reduce barriers to innovation in R&D. The session will include an overview of 3 webinars launched in Q2-Q3 2022: ● Collaborate to Innovate the Lab of the Future ● Data Science and Standards ● AI/ML in R&D Automation
2. D&I in STEM Leadership – program presentation This program is designed to help senior executives and team leaders develop their leadership capabilities and D&I knowledge. It provides a unique opportunity to connect with other leaders from across the life sciences industry, collaborate on best practices, and develop a personal network that will help strengthen career progression and D&I initiatives within our organization. Anca Ciobanu, Pistoia Alliance |
| 16:00
|
Methods Hub – the Methods Database Project
Pankaj Aggarwal, Merck, Ken Wells/Juliet McComas, GSK, Birthe Nielsen, Pistoia Alliance |
| 16.45 | Panel Discussion: Digital Transformation to support Emerging Science & Technology
Topics to be addressed include: ● Quantum Computing, New Research Modalities, Natural Language Generation ● How do you justify the investment? What is a reasonable RoI? ● What are the applications/challenges in the regulated domain? ● What should the Pistoia Alliance be doing? Chair: John Wise, Pistoia Alliance Jim Rinker, Elsevier Chris Waller, Pistoia Alliance Chairman of the BoD Further panelists to be confirmed |
| 17.30 | Meeting Close & Networking Reception |
Agenda – Conference Day – 2 November 2022
All timings are EST
| 09.00 | President’s introduction | Becky Upton, President, Pistoia Alliance | ||||||
| 09.15 | Keynote Presentation I: Regulatory Policy and Innovation
|
Khair ElZarrad, Director of the Office of Medical Policy, CDER, FDA | ||||||
| 09.45 | Keynote Presentation II: How can regulatory policy support innovation and pre-competitive collaboration? | Vada Perkins, Executive Director, Regulatory Policy & Innovation, Bayer | ||||||
| 10:10 | Pistoia Alliance Project Portfolio | VP, Project Portfolio, Pistoia Alliance | ||||||
| 10:30 | Keynote Panel Discussion: Innovation in Support of Sustainability in R&D |
|
||||||
| 11.10 | Morning Break | ● Poster viewing
● Exhibits |
||||||
| 11.40 | Partners in R&D Innovation | Elsevier, Collaborative Drug Discovery
The Power of Open – Red Hat’s approach to healthcare transformation Atif Chaughtai, Global Healthcare Market Leader, Red Hat
|
||||||
| 12.40 | Lunch | ● Poster viewing
● Birds of a feather roundtables ● Exhibits |
||||||
| 13.40 | Keynote Presentation III: The power of collaboration – a cross industry perspective | Ashish Kulkarni, EVP, Chief Innovation Officer, GAF, Board Member, Kebotics | ||||||
| 14.05 | The emerging landscape of RNA therapeutics | Gilles Georges, VP and Chief Scientific Officer, CAS
|
||||||
| 14.20 | Meet the New Pistoia Alliance Member | |||||||
| 13:00 | Lunch |
|
||||||
| 14.00 | Breakout One
Emerging Science & Technology Maryam Hosseini, Senior Solutions Architect, Elucidata Mya Steadman, Bioinformatics Scientist, Elucidata Copyright Clearance Center |
Breakout Two
Data Standards |
Breakout Three
The Skills Gam |
Breakout Four | ||||
| 15:15 | Coffee | |||||||
| 15.45 | Partners in R&D Innovation | |||||||
| 16.15 | Keynote Address IV – RWD
|
Christian Nguyen, Vice President, Global Patient Outcomes & Real World Evidence, Eli Lilly & Co | ||||||
| 16.45 | Panel Discussion: Application of RWD in Drug Discovery & Development | Matthias Leddin, Principal Data Scientist, Roche
Keele Wurst, Senior Director, Epidemiology, GSK Further panellists to be confirmed
|
||||||
| 17.30 | Closing Remarks, Poster Prizes | |||||||
| 17.45 | Drinks Reception | ● Poster viewing
● Exhibits |
||||||
Speakers
-
- Ashish Kulkarni, EVP, Chief Innovation Officer, GAF, Board Member, Kebotics
-
- Becky Upton, President, Pistoia Alliance
-
- Christian Nguyen, Vice President, Global Patient Outcomes & Real World Evidence, Eli Lilly & Co.
-
- Ginena Harkins, Director, Safety, Health & Environment, AstraZeneca
-
- Matthias Leddin, Principal Data Scientist, Roche
-
- Vada Perkins, Executive Director, Regulatory Policy & Innovation, Bayer
Event Sponsors
Evening Drinks Reception Sponsor
Sponsorship Opportunities
Our sponsor packages offer service companies the perfect opportunity to engage with senior-level R&D leaders from leading life science institutions. If you have a service offering for this community or want to demonstrate your thought leadership, please email Zahid Tharia about our sponsorship opportunities.